CL
BIIB icon

CPWM LLC’s Biogen BIIB Stock Holding History

CPWM LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-783
Closed -$214K – 255
2017
Q1 		$214K Sell
783
-383
-33% -$108K 0.05% 220
2016
Q4 		$331K Sell
1,166
-288
-20% -$85.4K 0.07% 170
2016
Q3 		$455K Sell
1,454
-18
-1% -$5.33K 0.1% 147
2016
Q2 		$356K Sell
1,472
-231
-14% -$60.9K 0.08% 170
2016
Q1 		$443K Sell
1,703
-52
-3% -$13.7K 0.1% 148
2015
Q4 		$538K Sell
1,755
-9
-0.5% -$2.59K 0.11% 134
2015
Q3 		$515K Buy
1,764
+707
+67% +$233K 0.11% 128
2015
Q2 		$427K Buy
1,057
+286
+37% +$115K 0.1% 123
2015
Q1 		$326K Buy
771
+11
+1% +$4.34K 0.09% 110
2014
Q4 		$258K Sell
760
-7
-0.9% -$2.27K 0.07% 134
2014
Q3 		$254K Buy
+767
New +$253K 0.09% 105

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPWM LLC's BIIB Position: Q2 2017 in Review

CPWM LLC sold out of Biogen (BIIB) in Q2 2017, closing a stake of 783 shares — an estimated $214K sold.

CPWM LLC first reported a position in BIIB in Q3 2014 and held it in 11 quarters. The position peaked at $538K in Q4 2015. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • CPWM LLC reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • CPWM LLC sold 783 Biogen shares in Q2 2017, an estimated $214K.
  • CPWM LLC first reported a position in Biogen in Q3 2014 and held it in 11 quarters.
  • CPWM LLC's Biogen position peaked at $538K in Q4 2015.
  • 993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on CPWM LLC's 13F filing for Q2 2017, filed 14 Aug 2017.